SEMAGLUTIDE / EFFECTS AND SAFETY
What Might Semaglutide Do, Good or Bad?
You’ll see study results beside personal reports, so you’ll know which claims have proof.
What benefits and harms might you notice?
Novo Nordisk wanted semaglutide to copy a gut hormone and last longer. People often report less hunger, fewer cravings, weight loss, and lower blood sugar. Those personal accounts aren’t proof from a study that compares groups. People also report nausea, burps, bowel changes, tiredness, headaches, and hair loss. If we were at my table, I’d keep that line clear so you know how much trust each claim earns.
Which benefits do people report after using Semaglutide?
People using semaglutide have said these things happened to them. Researchers didn’t gather or test these accounts in a group study. They’re individual experiences, not proof. You might notice something quite different.
Less pull toward food, reported often. Many people say food took up fewer thoughts during the first couple of weeks. They felt satisfied with less and ate a third to a half of their old portions. Such accounts can’t foretell your feeling. Your appetite may keep its own clock.
Fewer cravings, reported often. People say sweets and greasy foods lost some appeal. Some even found those foods unpleasant. Others preferred fruit, vegetables, and lighter meals after the opening weeks. You may not share that change in taste.
Weight loss, reported often. Most reviewers say their weight fell over several months. Many credit eating less more than added exercise. They also say the pace slowed after the early stretch. Their accounts won’t promise your result.
Better blood sugar, reported fairly often. People with type 2 diabetes often say daily readings and their longer blood-sugar measure fell. Some describe steadier energy through the day. These individual accounts can’t forecast your response. Your meter doesn’t have to match theirs.
Less interest in alcohol, reported occasionally. Alcohol sometimes loses appeal along with food cravings, people say. They often found that change unexpected. No trial result is being claimed here. You can’t count those reports as a proven benefit.
Which Semaglutide side effects do people report?
People using semaglutide also describe unwanted effects. Researchers didn’t collect or test this set of accounts in a group study. The reports offer clues, not proof. Your experience may differ.
Nausea and sometimes vomiting, reported often. Roughly a third of reviews mention nausea, and some people say they vomited when it was worst. They often place the worst spell near the start or a dose increase. Many say water and smaller, lighter meals helped, but your experience may differ.
Bad-smelling burps, reported fairly often. The smell is often likened to bad eggs and may last hours or weeks. People also mention bloating and a feeling that food sat too long. Some say the burps eased with time. Yours may follow another course.
Bowel changes, reported fairly often. Some people report hard, rare stools, while others report diarrhea. A few say the two problems took turns. Their accounts often blame rich food or the period following a dose. You won’t know which change, if any, you’d have.
Heartburn and early tiredness. People sometimes mention heartburn, burping, and bloating as the dose rises. Tiredness comes up most during a shot’s first two days and the early weeks. Many say it eased. Their reports can’t tell how long you might feel tired.
Food and smell changes. Some people say fatty or meaty food began tasting wrong, or smells became hard to bear. A few had to remind themselves to eat. Such a strong loss of appetite can matter when you’re already frail. You can’t assume that change is harmless.
Hair, face, head, and skin changes. Some people report shedding hair after a few months and a thinner face when weight fell fast. Others mention headaches, dizziness, or a small red, itchy bump at the injection spot. They often call those problems short-lived. Their accounts can’t promise what your skin or hair will do.
Which Semaglutide warnings need your attention?
These warnings come from studies, the approved label, and safety reports made after use. When a warning comes only from animals or early reports, I’ll say so. Some answers still aren’t settled. You’ll know what backs each warning.
Stomach and bowel trouble while the dose rises. Vomiting, diarrhea, constipation, and nausea made many people stop GLP-1 medicines, which copy a gut hormone. The trouble was often mild and brief, but it gathered near dose increases [20]. One review found nausea in roughly one of every three people [21]. Later safety reports centered on the same problems [22], so they aren’t just a theory.
An uncommon thyroid cancer in you or your family. The strongest label warning for GLP-1 medicines came from rodents given high amounts. Reports in people haven’t shown more cancer in hormone-making thyroid cells [23]. The label says people with medullary thyroid cancer, the rare kind meant here, mustn’t use semaglutide. MEN-2 stands for multiple endocrine neoplasia type 2, a rare illness passed down in families. It can cause tumors in several hormone-making glands [21]. You may know of that thyroid cancer or testing in relatives; your doctor can also check the family record.
A painful, swollen pancreas. Pancreatitis means sudden swelling of your pancreas, and this drug family carries a warning. Doctors normally end treatment when they suspect it. Cases were rare, so one safety review couldn’t tell whether pancreas cancer rose [21]. Rare trouble can still matter.
Gallbladder trouble, including stones. Reviewers found more gallbladder disease, including gallstones, in people taking semaglutide [21]. Fast or large weight loss may help explain why. Yet this trouble happened in people. It wasn’t only a lab concern.
Diabetic eyes may worsen when sugar falls fast. SUSTAIN-6 found more eye trouble in people who already had eye damage. Their long-term blood sugar had fallen quickly. A 95% check tests how much a result may shift by chance; this one backed the warning but couldn’t give your personal chance [3]. The cause isn’t settled; the fast drop may explain it. A safety review says doctors may check your eyes more closely after such a fall [21].
Loss of some muscle along with fat. A weight study grouped muscle with all tissue that wasn’t fat; it didn’t split out every kind [24]. Large, fast weight loss can weaken an older adult. People did lose muscle. The study couldn’t show later harm in everyone.
Weight returning after you stop. After STEP 1, a large weight study, average regain was roughly 11.6 points of body weight within one year [16]. Other health gains also moved toward old levels. In STEP 4, people changed from semaglutide to placebo, which held no semaglutide, and regained weight [15]. The medicine is viewed as ongoing care, not a cure.
Pregnancy and time for the drug to clear. The approved label says semaglutide mustn’t be used during pregnancy. After about five weeks, almost none remains; roughly half remains after one week. Before pregnancy, the label sets a long wait, often roughly two months [27]. That timing comes from the label.
The pill’s strict empty-stomach rule. Your body takes in only about 0.4-1% of oral semaglutide, even with an added ingredient [7]. The pill amount allows for that small share. Food, drink, or other pills can lower the share again [27]. A mistake may weaken the effect, but it won’t make the pill poisonous.
Other medicines that need an exact amount in your blood. One review found few cases where these drugs and semaglutide changed how the other worked, although GLP-1 medicines slow food leaving the stomach [28]. That doesn’t prove every mix is safe. Too little of some drugs may fail, while too much may harm you. The risk may rise as your semaglutide amount rises. Your prescriber can review your medicines and order closer blood tests when needed.
Does Semaglutide hair loss come from the drug?
Patients, doctors, and drug makers sent hair-loss reports to the FDA after semaglutide and tirzepatide came into use [25]. The report review didn’t count every user, so it can’t tell what share lost hair. A skin study linked loose, all-over shedding with faster and larger weight loss [26]. Hair lost this way often grows back, which points toward rapid weight change. Those papers don’t prove that the drugs harmed hair.
People often say shedding began a few months into weight loss. Fast loss is one possible cause if you notice it. Studies can’t tell how long your shedding might last. Your hair loss may have a different cause.
When did Semaglutide gain each approved use?
Novo Nordisk made semaglutide from liraglutide, an older GLP-1 medicine that copies a gut hormone. A change slows DPP-4, the enzyme that removes the natural hormone, so one dose lasts longer. Use for type 2 diabetes came in 2017, a daily pill in 2019-2020, and long-term weight care in 2021. Researchers reported heart findings in 2023, and the added heart use followed in 2024. Kidney findings came in 2024, and that use followed in 2025. MASH was added in 2025 [6][3][4][5][1].
STEP 1 studied weight, while SUSTAIN-6 tracked heart trouble. Later work covered kidneys and liver disease. From roughly 2022 until early 2025, shortage rules let compounding pharmacies prepare semaglutide. Officials narrowed that broad permission in early 2025. A compounded drug still can’t claim the same proof.